HCPCS Level II · Temporary national codes (non-Medicare)
S0077Injection, clindamycin phosphate, 300 mg
Terminated 06/30/2023
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About S0077
S0077 is an HCPCS Level II code in the S series (temporary national codes (non-Medicare)), describing injection, clindamycin phosphate, 300 mg.
It was added to HCPCS effective 01/01/2000, and its current record took effect 07/01/2023.
It was terminated on 06/30/2023 and can't be billed for later dates of service.
Its Medicare coverage code is "I", meaning it is not payable by Medicare (another code or method is used).
Details
- Short description
- Injection, clindamycin phosp
- Date added
- 01/01/2000
- Action effective
- 07/01/2023
- Termination date
- 06/30/2023
- BETOS
- Z2
Related S00xx codes
- S0012Butorphanol tartrate, nasal spray, 25 mg
- S0014Tacrine hydrochloride, 10 mg
- S0021Injection, cefoperazone sodium, 1 gram
- S0023Injection, cimetidine hydrochloride, 300 mg
- S0034Injection, ofloxacin, 400 mg
- S0040Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams
- S0078Injection, fosphenytoin sodium, 750 mg
- S0081Injection, piperacillin sodium, 500 mg
- S0088Imatinib, 100 mg
- S0090Sildenafil citrate, 25 mg
- S0091Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)
- S0092Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)
Common questions about S0077
Is HCPCS S0077 still valid?
- No. S0077 was terminated on 06/30/2023.
Does Medicare cover S0077?
- Its coverage code is "I": it is not payable by Medicare (another code or method is used). Check the local coverage determination for your region.